Tumor-directed evolution of VSVΔ51M produces novel viruses with enhanced antitumor efficacy

Oncolytic virotherapy has gained enormous attention and is undergoing extensive research, specifically, the Vesicular Stomatitis Virus (VSV). VSV has been shown to provide a potential tool on which many modifications can be introduced to improve its efficacy. Here we report utilizing a modified VSV...

Descripció completa

Dades bibliogràfiques

Autors principals:	Omar A. Albaradie, Abdulaziz Molham Moglan, Yahya Marwan Samman, Fares Fayez Alsayegh, Hussam Mohsen Alharbi, Nada Almarghalani, Khulood Alotaibi, Mohammed M. Jalal, Malik A. Altayar, Nizar H. Saeedi, Hanan A. Niaz, Samer Zakri, Adnan Almuzaini, Feras Kaboha, Saleh Y. Alabbas, Yasmeen A. Albalawi, Abeer Alsofyani, Adrian Pelin, May Abdulaiz Alsayb, Shymaa Damfo, Ahmad Bakur Mahmoud, Almohanad A. Alkayyal
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-05-01
Col·lecció:	Frontiers in Molecular Biosciences
Matèries:	oncolytic virotherapy personalized therapy vesicular stomatitis virus viral evolution VSVΔ51M
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fmolb.2026.1656006/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!